Coloplast A/S (COLOb.CO)
333.20DKK
22 May 2013
kr.4.50 (+1.37%)
kr.328.70
kr.328.70
kr.333.70
kr.327.50
336,661
494,850
kr.334.50
kr.197.10
About
Overall
| Beta: | 0.22 |
| Market Cap (Mil.): | kr.66,397.40 |
| Shares Outstanding (Mil.): | 202.00 |
| Dividend: | 3.00 |
| Yield (%): | 1.52 |
Financials
| COLOb.CO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 28.52 | 30.14 | 35.13 |
| EPS (TTM): | 11.53 | -- | -- |
| ROI: | 34.11 | 10.40 | 18.83 |
| ROE: | 43.36 | 13.41 | 19.68 |
UPDATE 1-Denmark's Coloplast to pay special dividend, shares jump
COPENHAGEN, April 30 - Shares in Danish healthcare product maker Coloplast jumped almost 5 percent on Tuesday after it announced a one-off dividend, rewarding shareholders after quarterly earnings grew in all of its business units.
Coloplast sticks to year forecast despite miss on Q2 profits
COPENHAGEN, April 30 - Danish healthcare products maker Coloplast stood by its outlook for the full year after second quarter operating profits rose 12 percent, missing forecasts.
Coloplast cuts sales forecast on currency swings
COPENHAGEN - Danish healthcare product maker Coloplast cut its full-year Danish-crown sales forecast on Wednesday due to unfavorable currency developments, after reporting first-quarter results roughly in line with forecasts.
UPDATE 1-Coloplast cuts sales forecast on currency swings
* Keeps FY outlook unchanged in local currencies, cuts in DKK
Coloplast Q1 EBIT narrowly beats forecasts
COPENHAGEN, Jan 30 - Danish healthcare products maker Coloplast on Wednesday reported first-quarter operating profits just above expectations.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

